Topics in Companion Animal Medicine
Volume 25, Issue 1 , Pages 5-9 , February 2010

Chronic Pain: Pathophysiology and Treatment Implications

  • Stephen A. Greene, DVM, MS, DACVA

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Stephen A. Greene, DVM, MS, DACVA, Professor of Veterinary Anesthesia, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-6610

References 

  1. Lamont LA, Tranquilli WJ, Grimm KA. Physiology of pain. Vet Clin North Am. 2000;30:703–728
  2. Tranquilli WJ. Physiology of chronic pain. In:  Greene SA editors. Veterinary Anesthesia and Pain Management Secrets. Philadelphia: Elsevier; 2002;p. 345–348
  3. Stanfa L, Ah D, Xu X, Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci. 1994;15:65–66
  4. Pozzi A, Muir WW, Traverso F. Prevention of central sensitization and pain by N-methyl-D-aspartate receptor antagonists. J Am Vet Med Assoc. 2006;228:53–60
  5. Bizzarri C, Pagliei S, Brandolini L, et al. Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers. Biochem Pharmacol. 2001;61:1429–1437
  6. Wiertelek E, Maier S, Watkins L. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science. 1992;256:830–833
  7. Twycross RG. Opioids. In:  Wall PD,  Melzak R editor. Pain. Edinburgh: Churchill-Livingstone; 1999;p. 1187–1214
  8. Kona-Boun J-J, Silim A, Troncy E. Immunologic aspects of veterinary anesthesia and analgesia. J Am Vet Med Assoc. 2005;226:355–363
  9. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992;263:136–146
  10. Bryant CE, Farnfield BA, Janicke HJ. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Am J Vet Res. 2003;64:211–215
  11. Trang T, McNaull B, Quirion R, et al. Involvement of spinal lipoxygenase metabolites in hyperalgesia and opiate tolerance. Eur J Pharmacol. 2004;491:21–30
  12. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2005;79:9–19
  13. Robertson SA, Taylor PM, Sear JW. Systemic uptake of buprenorphine by cats after oral mucosal administration. Vet Rec. 2003;152:675–678
  14. Veri A, D'Andrea MR, Bonginelli P, et al. Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers. Int J Biol Markers. 2007;22:24–33
  15. Matthews KA. Neuropathic pain in dogs and cats: if only they could tell us if they hurt. Vet Clin North Am. 2008;38:1365–1414
  16. Muth-Selbach U, Hermanns H, Stegmann JU, et al. Antinociceptive effects of systemic lidocaine: involvement of the spinal glycinergic system. Eur J Pharmacol. 2009;613:68–73
  17. Proudfoot CJ, Garry EM, Cottrell DF, et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Current Biol. 2006;16:1591–1605
  18. Karavis M. The neurophysiology of acupuncture: a viewpoint. Acupunct Med. 1997;15(1):33–42

PII: S1938-9736(09)00102-0

doi: 10.1053/j.tcam.2009.10.009

Topics in Companion Animal Medicine
Volume 25, Issue 1 , Pages 5-9 , February 2010

Article Tools

* Image Usage & Resolution